Lithium suppliers

Properties

Melting point:：

180 °C (lit.)

Boiling point:：

1342 °C (lit.)

Density ：

0.534 g/mL at 25 °C (lit.)

vapor pressure ：

1 hPa (723 °C)

storage temp. ：

water-free area

solubility ：

reacts with H2O

form ：

wire

Specific Gravity：

0.534

color ：

Silvery

Odor：

Odorless

PH Range：

>12

PH：

5.0 (20°C in H2O)

Flame Color：

Pink-red or magenta

Resistivity：

9.446 μΩ-cm, 20°C

Water Solubility ：

REACTS

Sensitive ：

air sensitive, moisture sensitive

Merck ：

13,5542

Exposure limits：

ACGIH: TWA 2 ppm; STEL 4 ppm
OSHA: TWA 2 ppm(5 mg/m3)
NIOSH: IDLH 25 ppm; TWA 2 ppm(5 mg/m3); STEL 4 ppm(10 mg/m3)

Stability:：

Stable, but reacts violently with water.

LogP：

-0.77 at 25℃

Hardness, Vickers：

<= 5.0

CAS DataBase Reference：

7439-93-2(CAS DataBase Reference)

NIST Chemistry Reference：

Lithium(7439-93-2)

EPA Substance Registry System：

Lithium (7439-93-2)

SecurityInformation

Symbol(GHS) ：

GHS02,GHS05

Signal word ：

Danger

Hazard statements ：

H260-H314

Precautionary statements ：

P223-P231+P232-P280-P305+P351+P338-P370+P378-P422

Hazard Codes ：

Xi,C,F

Risk Statements ：

36/38-34-14/15-23

Safety Statements ：

8-43-45-43C-36/37/39-26

RIDADR ：

UN 3264 8/PG 3

WGK Germany ：

2

RTECS ：

OJ5540000

F ：

10

Autoignition Temperature：

179oC

TSCA ：

Yes

HS Code ：

2805 19 90

HazardClass ：

4.3

PackingGroup ：

I

Hazardous Substances Data：

7439-93-2(Hazardous Substances Data)

Toxicity：

An element used clinically as one of its salts. It is effective against both mania and depression. Despite its effectiveness, there are no clear mechanisms that have been directly related to its therapeutic effectiveness although its inhibition of the formation of inositol from inositol phosphate is thought to be important. At therapeutic concentrations, lithium causes almost no discernible psychotropic effects in healthy humans. The major complaints when the serum concentrations of the drug are carefully monitored include slight muscular weakness, thirst, and excessive urination. The major difficulty with lithium is that a fairly high concentration of the ion is needed in the blood (0.5_x0002_1.0 mmol/L) for maintenance, higher for acute mania. Toxic symptoms (which can involve many physiological symptoms) may occur, however, at doses of 1.5 mmol/L or higher. This low therapeutic index is indicative of the need for regular monitoring of lithium concentrations in the serum.